Aura Biosciences Inc (AURA)

Aura Biosciences Inc stock is traded at $6.65, with a volume of 1,002,673. It is up +6.57% in the last 24 hours and up +9.20% over the past month. Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.